Profil
Satu Lindgren is currently the Director of Quality, Regulatory & Clinical at BonAlive Biomaterials Oy since 2010.
Prior to this, Lindgren worked as a Principal at Vivoxid Oy.
Aktive Positionen von Satu Lindgren
| Unternehmen | Position | Beginn |
|---|---|---|
BonAlive Biomaterials Oy
 BonAlive Biomaterials Oy Medical SpecialtiesHealth Technology BonAlive Biomaterials Oy is a holding company that provides solutions to heal patients with bone defects. It develops synthetic biomaterial solutions for the treatment of chronically infected bone. Their products include BonAlive granules and BonAlive putty, which are osteostimulative; BonAlive granules, which inhibits bacterial growth and act as tool for bone cavity filling in the treatment of chronic osteomyelitis; and BonAlive plates, which have been designed for repair of orbital floor trauma. The company was founded by Fredrik Viktor Ollila on November 13, 2009 and is headquartered in Turku, Finland. | General Counsel | 13.09.2010 |
Ehemalige bekannte Positionen von Satu Lindgren
| Unternehmen | Position | Ende |
|---|---|---|
Vivoxid Oy
 Vivoxid Oy BiotechnologyHealth Technology Vivoxid Oy develops, manufactures and markets biomaterial products and production services within the medical device sector. The company was founded on January 14, 2002 and is headquartered in Helsinki, Finland. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
BonAlive Biomaterials Oy
BonAlive Biomaterials Oy Medical SpecialtiesHealth Technology BonAlive Biomaterials Oy is a holding company that provides solutions to heal patients with bone defects. It develops synthetic biomaterial solutions for the treatment of chronically infected bone. Their products include BonAlive granules and BonAlive putty, which are osteostimulative; BonAlive granules, which inhibits bacterial growth and act as tool for bone cavity filling in the treatment of chronic osteomyelitis; and BonAlive plates, which have been designed for repair of orbital floor trauma. The company was founded by Fredrik Viktor Ollila on November 13, 2009 and is headquartered in Turku, Finland. | Health Technology |
Vivoxid Oy
Vivoxid Oy BiotechnologyHealth Technology Vivoxid Oy develops, manufactures and markets biomaterial products and production services within the medical device sector. The company was founded on January 14, 2002 and is headquartered in Helsinki, Finland. | Health Technology |
